Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.

Clinical trial NCT07288489 · RECRUITING

Trial details

NCT number: NCT07288489
Sponsor: VarmX B.V.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Blood Loss, Surgical Coagulation Disorder

Start date: 2026-08-18
Primary completion: 2029-01-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.